Trademark: 88640411
Word
DRIVEN BY OUR COMMUNITY
Status Date
Monday, August 7, 2023
Filing Date
Thursday, October 3, 2019
Published for Opposition
Tuesday, May 12, 2020
Abandoned Date
Monday, August 7, 2023
41 Education services, namely, providing classes, seminars, and workshops in the field of health care and treatment; Providing on-line non-downloadable publications in the nature of magazines, newsletters, journals, and articles, all in the fields of pharmaceuticals and clinical trials; Educational services, namely, providing displays and exhibits in the fields of health and medical treatment; Educational services, namely, conducting programs in the fields of health and medical treatment; Educational services, namely, providing panel discussions in the fields of health and medical treatment; Publication of periodicals featuring the results of clinical trials
16 Instructional publications, namely, hand-outs and workbooks in the fields of pharmaceutical products, vaccines, blood, blood products, and blood conditions; Printed instructional and teaching materials in the field of health products and services, pamphlets and informational flyers in the field of health products and services
44 Providing medical information and treatment information in the field of health; medical services; medical testing and screening services for diagnostic or treatment purposes; medical testing of human blood plasma for diagnostic or treatment purposes; collection of human blood plasma; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matter
42 Providing medical and scientific research information in the field of health and pharmaceuticals; Medical laboratory services, namely, scientific testing and screening services for testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma, Scientific research; research and development services, namely, scientific, medical, pharmaceutical and blood products research and development services; Providing medical and scientific research information in the field of pharmaceuticals, clinical trials, blood conditions, blood illnesses and blood diseases
Aug 7, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 7, 2023
Abandonment - No Use Statement Filed
Dec 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 28, 2022
Sou Extension 5 Granted
Dec 9, 2022
Sou Extension 5 Filed
Dec 28, 2022
Case Assigned To Intent To Use Paralegal
Dec 9, 2022
Teas Extension Received
Jun 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2022
Sou Extension 4 Granted
Jun 7, 2022
Sou Extension 4 Filed
Jun 7, 2022
Teas Extension Received
Dec 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 7, 2021
Sou Extension 3 Granted
Dec 7, 2021
Sou Extension 3 Filed
Dec 7, 2021
Teas Extension Received
Jun 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2021
Sou Extension 2 Granted
Jun 7, 2021
Sou Extension 2 Filed
Jun 7, 2021
Teas Extension Received
Jan 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2021
Sou Extension 1 Granted
Jan 4, 2021
Sou Extension 1 Filed
Jan 4, 2021
Teas Extension Received
Jul 7, 2020
Noa E-Mailed - Sou Required From Applicant
May 12, 2020
Official Gazette Publication Confirmation E-Mailed
May 12, 2020
Published For Opposition
Apr 22, 2020
Notification Of Notice Of Publication E-Mailed
Apr 3, 2020
Approved For Pub - Principal Register
Apr 3, 2020
Teas/Email Correspondence Entered
Apr 3, 2020
Correspondence Received In Law Office
Apr 3, 2020
Assigned To Lie
Mar 26, 2020
Teas Response To Office Action Received
Dec 5, 2019
Notification Of Non-Final Action E-Mailed
Dec 5, 2019
Non-Final Action E-Mailed
Dec 5, 2019
Non-Final Action Written
Dec 3, 2019
Assigned To Examiner
Oct 7, 2019
New Application Office Supplied Data Entered
Oct 7, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
